News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
254 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17604)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (258)
2 (248)
3 (119)
4 (1)
5 (30)
6 (211)
7 (196)
8 (187)
9 (224)
10 (123)
11 (42)
12 (30)
13 (282)
14 (254)
15 (234)
16 (227)
17 (162)
18 (1)
19 (7)
20 (203)
21 (157)
22 (183)
23 (103)
24 (13)
25 (1)
27 (71)
28 (66)
29 (85)
30 (85)
31 (20)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
27
28
29
30
31
Drug Development
Immunic, Inc. Publishes Positive Results from the Single and Multiple Ascending Dose Parts of its Phase 1 Clinical Trial of IMU-935, a Potentially Best-in-Class Oral IL-17 Inhibitor
Unblinded Data Established a Favorable Safety and Tolerability Profile for IMU-935 in Single Dose and 14-Day Multiple Dose Assessments in Healthy Human Subjects.
December 14, 2021
·
9 min read
Drug Development
Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death
Pfizer Inc. today announced final results from an analysis of all 2,246 adults enrolled in its Phase 2/3 EPIC-HR trial of its novel COVID-19 oral antiviral candidate PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets).
December 14, 2021
·
16 min read
Deals
Evelo Biosciences Added to Nasdaq Biotechnology Index
Evelo Biosciences, Inc. today announced that the Company has been added to the NASDAQ Biotechnology Index ® (Nasdaq: NBI), effective prior to market open on December 20, 2021.
December 14, 2021
·
4 min read
Drug Development
TYME Technologies, Inc. Announces Additional Encouraging Preclinical Data on the Effect of TYME-19 in SARS CoV-2 Infections
TYME-19 demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells, a model frequently used for drug screening for antiviral efficacy.
December 14, 2021
·
9 min read
Drug Development
PharmaTher Announces Positive Research Results for LSD Microneedle Patch
Delivering LSD via microneedle patch unlocks potential for desired dosage forms and pharmacokinetic profiles for improved safety and effectiveness Pursuing Phase 2 clinical studies in 2022 with LSD and notable psychedelics.
December 14, 2021
·
5 min read
FDA
Tonix Pharmaceuticals Announces IND Clearance for Skin Test (TNX-2100) to Measure SARS-CoV-2 Exposure and T Cell Immunity
Tonix Pharmaceuticals Holding Corp. today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application to initiate a first-in-human clinical study for TNX-2100.
December 14, 2021
·
9 min read
Business
BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT
Bio-Techne Corporation today announced it has entered into an option agreement with Wilson Wolf Corporation.
December 14, 2021
·
5 min read
Business
Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid Tumors
Synthetic Biologics, Inc. today announced it has signed a definitive agreement to acquire VCN Biosciences, S.L.
December 14, 2021
·
14 min read
Business
SAS and PERSOWN drive lifesaving insights to reduce COVID spread, improve global health
Analytics leader SAS is partnering with medical diagnostics and technology startup PERSOWN, formerly known as Blink Science, to bring affordable, lifesaving technologies to the billions of traditionally underserved people of the world.
December 14, 2021
·
2 min read
Business
OcuTerra Appoints Barbara Ryan to Board of Directors
OcuTerra Therapeutics, Inc. today announced the appointment of Barbara Ryan to its Board of Directors.
December 14, 2021
·
4 min read
Previous
7 of 26
Next